Spex Capital

Headquarters
United KingdomLondon, United Kingdom
Founded
Founded 2021
Company size
11-50 employees
LinkedIn
LinkedIn
Report correction
United KingdomUkraineTurkeySwitzerlandSwedenSpainSlovakiaSloveniaSerbiaRomaniaPortugalPolandNorwayNetherlandsMontenegroMoldovaMaltaNorth MacedoniaLuxembourgLithuaniaLatviaKosovoItalyIrelandIcelandHungaryGreeceGermanyFranceFinlandEstoniaDenmarkCzech RepublicCyprusCroatiaBulgariaBosniaBelgiumBelarusAustriaAlbania
Headquartered in London, United Kingdom

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds
1
Reported volume
€30m
Latest public closing
14 Oct 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

London-based early-stage venture capital firm investing in digital health and medtech.

Focus: Early-stage digital health and medtech ventures, including technologies to improve healthcare delivery globally

14 October 2025: Spex Capital reported €30m of commitments for its Venture HealthTech Fund against a €100m target (EU-Startups, Tech Funding News).

Tracked funds

Showing 1 of 1 funds